• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jnmaLink to Publisher's site
J Natl Med Assoc. Dec 2007; 99(12): 1381–1385.
PMCID: PMC2575931

Jaundice in African-American and Hispanic patients with AIDS.

Abstract

Although abnormalities in hepatic biochemical tests are common in patients with acquired immunodeficiency syndrome (AIDS), overt jaundice is infrequent. The aim of this study was to investigate the etiology and outcome of jaundice in African-American and Hispanic patients with AIDS. We retrospectively reviewed medical records of 1,238 HIV-infected patients with abnormal liver chemistry over a 10-year period. Data were abstracted and analyzed for demography, medications, laboratory tests, abdominal ultrasonography, computerized tomography (CT), magnetic resonance imaging (MRI), endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic cholangiography (PTC) and liver biopsy results. Of 1,238 patients with abnormal liver chemistry and HIV infection, 1,040 (84%) had AIDS. Of the 1,040 AIDS patients, 102 (10%) had jaundice (serum bilirubin >3 mg/dL). Of the 198 HIV-positive patients without AIDS and with abnormal liver chemistry, none had jaundice. The common causes of jaundice were drugs (29%) and infections (28%). Liver biopsy was performed in 20 AIDS patients, and the common findings included granulomas, Mycobacterium avium complex (25%) and Kaposi's sarcoma (25%). Of 102 patients with AIDS and jaundice, 72 (70%) died. Of the 198 patients without AIDS and without jaundice, 14 (7%) died. In conclusion, liver-associated enzyme abnormality was common among our patients with AIDS; however, jaundice was infrequent and associated with a high mortality; drugs, infections and alcohol were the common culprits.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Racial/ethnic disparities in diagnoses of HIV/AIDS--33 states, 2001-2004. MMWR Morb Mortal Wkly Rep. 2006 Feb 10;55(5):121–125. [PubMed]
  • Puoti M, Spinetti A, Ghezzi A, Donato F, Zaltron S, Putzolu V, Quiros-Roldan E, Zanini B, Casari S, Carosi G. Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr. 2000 Jul 1;24(3):211–217. [PubMed]
  • Lefkowitch JH. The liver in AIDS. Semin Liver Dis. 1997;17(4):335–344. [PubMed]
  • Bénichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol. 1990 Sep;11(2):272–276. [PubMed]
  • Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology. 1997 Sep;26(3):664–669. [PubMed]
  • Björnsson Einar. Drug-induced liver injury: Hy's rule revisited. Clin Pharmacol Ther. 2006 Jun;79(6):521–528. [PubMed]
  • Anderson Robert N, Smith Betty L. Deaths: leading causes for 2002. Natl Vital Stat Rep. 2005 Mar 7;53(17):1–89. [PubMed]
  • Funnyé Allen S, Akhtar Abbasi J, Biamby Gisele. Acquired immunodeficiency syndrome in older African Americans. J Natl Med Assoc. 2002 Apr;94(4):209–214. [PMC free article] [PubMed]
  • Selwyn Peter A, Rivard Mimi. Palliative care for AIDS: challenges and opportunities in the era of highly active anti-retroviral therapy. J Palliat Med. 2003 Jun;6(3):475–487. [PubMed]
  • Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman DR. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001 Feb 1;32(3):492–497. [PubMed]
  • Funnyé Allen S, Akhtar Abbasi J. Syphilis and human immunodeficiency virus co-infection. J Natl Med Assoc. 2003 May;95(5):363–382. [PMC free article] [PubMed]
  • Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA. 2000 Jan 5;283(1):74–80. [PubMed]
  • Bhattacharya Debika, Imperial Joanne C, Keeffe Emmet B. Chronic hepatitis C in the human immunodeficiency virus-infected patient: management strategies. Clin Gastroenterol Hepatol. 2006 Mar;4(3):288–292. [PubMed]
  • Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, Koziel MJ. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001 Aug 15;33(4):562–569. [PubMed]
  • Wnuk AM. Liver damage in HIV-infected patients. Med Sci Monit. 2001 Jul-Aug;7(4):729–736. [PubMed]
  • Stahmer I, Ordonez C, Popovic M, Mesquita R, Ekman M, Albert J, Putkonen P, Böttiger D, Biberfeld G, Biberfeld P. SIV infection of monkey spleen cells including follicular dendritic cells in different stages of disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jan 1;11(1):1–9. [PubMed]
  • Weber Rainer, Sabin Caroline A, Friis-Møller Nina, Reiss Peter, El-Sadr Wafaa M, Kirk Ole, Dabis Francois, Law Matthew G, Pradier Christian, De Wit Stephane, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006 Aug 14;166(15):1632–1641. [PubMed]
  • Akhtar AJ, Ganesan K, Yoshikawa TT. Upper gastrointestinal hemorrhage in African-American and Hispanic elderly patients. Ethn Dis. 2001 Winter;11(1):7–10. [PubMed]
  • Akhtar Abbasi J. Lower gastrointestinal hemorrhage in African-American and Hispanic elderly patients. Ethn Dis. 2002 Summer;12(3):379–382. [PubMed]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links